English
简体中文
Total: £ 56.28
Published Date: 2025-07-16 | Pages: 111 | Tables: 113 | Pharma & Healthcare
The global market for Bispecific Antibody Medicine was valued at US$ 8558 million in the year 2024 and is projected to reach a revised size of US$ 53503 million by 2031, growing at a CAGR of 35.3% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Bispecific Antibody Medicine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Bispecific antibody medicine, are a type of engineered antibody that can simultaneously recognize and bind to two different antigens or antigen epitopes. Compared with traditional monoclonal antibodies (monospecific antibodies), bispecific antibody drugs have more complex target regulation capabilities and show great therapeutic potential in the fields of tumor immunity, infectious diseases, and autoimmune diseases.
North American market for Bispecific Antibody Medicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bispecific Antibody Medicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Bispecific Antibody Medicine include Roche (Genentech), Amgen, Regeneron Pharmaceuticals, AstraZeneca, Novartis, Merck & Co., Pfizer, Eli Lilly and Company, Johnson & Johnson, AbbVie, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibody Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibody Medicine.
The Bispecific Antibody Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bispecific Antibody Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bispecific Antibody Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Roche (Genentech)
Amgen
Regeneron Pharmaceuticals
AstraZeneca
Novartis
Merck & Co.
Pfizer
Eli Lilly and Company
Johnson & Johnson
AbbVie
Sanofi
Takeda
Lindis Biotech
Bristol Myers Squibb
Akeso Biopharma
Alphamab Oncology
Innovent Biologics
Wuhan YZY Biopharma Co., Ltd.
BeiGene
Xencor
Zymeworks
MacroGenics, Inc
Genmab
Immunocore Limited
Affimed
Segment by Type
T Cell Redirection Type
Immune Modulation Type
Dual Pathway Blockade Type
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bispecific Antibody Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bispecific Antibody Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Bispecific Antibody Medicine Market Overview
1.1 Product Definition
1.2 Bispecific Antibody Medicine by Type
1.2.1 Global Bispecific Antibody Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 T Cell Redirection Type
1.2.3 Immune Modulation Type
1.2.4 Dual Pathway Blockade Type
1.3 Bispecific Antibody Medicine by Application
1.3.1 Global Bispecific Antibody Medicine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Bispecific Antibody Medicine Market Size Estimates and Forecasts
1.4.1 Global Bispecific Antibody Medicine Revenue 2020-2031
1.4.2 Global Bispecific Antibody Medicine Sales 2020-2031
1.4.3 Global Bispecific Antibody Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bispecific Antibody Medicine Market Competition by Manufacturers
2.1 Global Bispecific Antibody Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bispecific Antibody Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bispecific Antibody Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bispecific Antibody Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bispecific Antibody Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bispecific Antibody Medicine, Product Type & Application
2.7 Global Key Manufacturers of Bispecific Antibody Medicine, Date of Enter into This Industry
2.8 Global Bispecific Antibody Medicine Market Competitive Situation and Trends
2.8.1 Global Bispecific Antibody Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bispecific Antibody Medicine Players Market Share by Revenue
2.8.3 Global Bispecific Antibody Medicine Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bispecific Antibody Medicine Market Scenario by Region
3.1 Global Bispecific Antibody Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bispecific Antibody Medicine Sales by Region: 2020-2031
3.2.1 Global Bispecific Antibody Medicine Sales by Region: 2020-2025
3.2.2 Global Bispecific Antibody Medicine Sales by Region: 2026-2031
3.3 Global Bispecific Antibody Medicine Revenue by Region: 2020-2031
3.3.1 Global Bispecific Antibody Medicine Revenue by Region: 2020-2025
3.3.2 Global Bispecific Antibody Medicine Revenue by Region: 2026-2031
3.4 North America Bispecific Antibody Medicine Market Facts & Figures by Country
3.4.1 North America Bispecific Antibody Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bispecific Antibody Medicine Sales by Country (2020-2031)
3.4.3 North America Bispecific Antibody Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bispecific Antibody Medicine Market Facts & Figures by Country
3.5.1 Europe Bispecific Antibody Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bispecific Antibody Medicine Sales by Country (2020-2031)
3.5.3 Europe Bispecific Antibody Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bispecific Antibody Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Bispecific Antibody Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bispecific Antibody Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Bispecific Antibody Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bispecific Antibody Medicine Market Facts & Figures by Country
3.7.1 Latin America Bispecific Antibody Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bispecific Antibody Medicine Sales by Country (2020-2031)
3.7.3 Latin America Bispecific Antibody Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bispecific Antibody Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Bispecific Antibody Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bispecific Antibody Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bispecific Antibody Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bispecific Antibody Medicine Sales by Type (2020-2031)
4.1.1 Global Bispecific Antibody Medicine Sales by Type (2020-2025)
4.1.2 Global Bispecific Antibody Medicine Sales by Type (2026-2031)
4.1.3 Global Bispecific Antibody Medicine Sales Market Share by Type (2020-2031)
4.2 Global Bispecific Antibody Medicine Revenue by Type (2020-2031)
4.2.1 Global Bispecific Antibody Medicine Revenue by Type (2020-2025)
4.2.2 Global Bispecific Antibody Medicine Revenue by Type (2026-2031)
4.2.3 Global Bispecific Antibody Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Bispecific Antibody Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bispecific Antibody Medicine Sales by Application (2020-2031)
5.1.1 Global Bispecific Antibody Medicine Sales by Application (2020-2025)
5.1.2 Global Bispecific Antibody Medicine Sales by Application (2026-2031)
5.1.3 Global Bispecific Antibody Medicine Sales Market Share by Application (2020-2031)
5.2 Global Bispecific Antibody Medicine Revenue by Application (2020-2031)
5.2.1 Global Bispecific Antibody Medicine Revenue by Application (2020-2025)
5.2.2 Global Bispecific Antibody Medicine Revenue by Application (2026-2031)
5.2.3 Global Bispecific Antibody Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Bispecific Antibody Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche (Genentech)
6.1.1 Roche (Genentech) Company Information
6.1.2 Roche (Genentech) Description and Business Overview
6.1.3 Roche (Genentech) Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche (Genentech) Bispecific Antibody Medicine Product Portfolio
6.1.5 Roche (Genentech) Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Bispecific Antibody Medicine Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Regeneron Pharmaceuticals
6.3.1 Regeneron Pharmaceuticals Company Information
6.3.2 Regeneron Pharmaceuticals Description and Business Overview
6.3.3 Regeneron Pharmaceuticals Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Regeneron Pharmaceuticals Bispecific Antibody Medicine Product Portfolio
6.3.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Company Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca Bispecific Antibody Medicine Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Bispecific Antibody Medicine Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Merck & Co.
6.6.1 Merck & Co. Company Information
6.6.2 Merck & Co. Description and Business Overview
6.6.3 Merck & Co. Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck & Co. Bispecific Antibody Medicine Product Portfolio
6.6.5 Merck & Co. Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Bispecific Antibody Medicine Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Eli Lilly and Company
6.8.1 Eli Lilly and Company Company Information
6.8.2 Eli Lilly and Company Description and Business Overview
6.8.3 Eli Lilly and Company Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Eli Lilly and Company Bispecific Antibody Medicine Product Portfolio
6.8.5 Eli Lilly and Company Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Company Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Johnson & Johnson Bispecific Antibody Medicine Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 AbbVie
6.10.1 AbbVie Company Information
6.10.2 AbbVie Description and Business Overview
6.10.3 AbbVie Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 AbbVie Bispecific Antibody Medicine Product Portfolio
6.10.5 AbbVie Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Company Information
6.11.2 Sanofi Description and Business Overview
6.11.3 Sanofi Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sanofi Bispecific Antibody Medicine Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Takeda
6.12.1 Takeda Company Information
6.12.2 Takeda Description and Business Overview
6.12.3 Takeda Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Takeda Bispecific Antibody Medicine Product Portfolio
6.12.5 Takeda Recent Developments/Updates
6.13 Lindis Biotech
6.13.1 Lindis Biotech Company Information
6.13.2 Lindis Biotech Description and Business Overview
6.13.3 Lindis Biotech Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Lindis Biotech Bispecific Antibody Medicine Product Portfolio
6.13.5 Lindis Biotech Recent Developments/Updates
6.14 Bristol Myers Squibb
6.14.1 Bristol Myers Squibb Company Information
6.14.2 Bristol Myers Squibb Description and Business Overview
6.14.3 Bristol Myers Squibb Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bristol Myers Squibb Bispecific Antibody Medicine Product Portfolio
6.14.5 Bristol Myers Squibb Recent Developments/Updates
6.15 Akeso Biopharma
6.15.1 Akeso Biopharma Company Information
6.15.2 Akeso Biopharma Description and Business Overview
6.15.3 Akeso Biopharma Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Akeso Biopharma Bispecific Antibody Medicine Product Portfolio
6.15.5 Akeso Biopharma Recent Developments/Updates
6.16 Alphamab Oncology
6.16.1 Alphamab Oncology Company Information
6.16.2 Alphamab Oncology Description and Business Overview
6.16.3 Alphamab Oncology Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Alphamab Oncology Bispecific Antibody Medicine Product Portfolio
6.16.5 Alphamab Oncology Recent Developments/Updates
6.17 Innovent Biologics
6.17.1 Innovent Biologics Company Information
6.17.2 Innovent Biologics Description and Business Overview
6.17.3 Innovent Biologics Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Innovent Biologics Bispecific Antibody Medicine Product Portfolio
6.17.5 Innovent Biologics Recent Developments/Updates
6.18 Wuhan YZY Biopharma Co., Ltd.
6.18.1 Wuhan YZY Biopharma Co., Ltd. Company Information
6.18.2 Wuhan YZY Biopharma Co., Ltd. Description and Business Overview
6.18.3 Wuhan YZY Biopharma Co., Ltd. Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Wuhan YZY Biopharma Co., Ltd. Bispecific Antibody Medicine Product Portfolio
6.18.5 Wuhan YZY Biopharma Co., Ltd. Recent Developments/Updates
6.19 BeiGene
6.19.1 BeiGene Company Information
6.19.2 BeiGene Description and Business Overview
6.19.3 BeiGene Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.19.4 BeiGene Bispecific Antibody Medicine Product Portfolio
6.19.5 BeiGene Recent Developments/Updates
6.20 Xencor
6.20.1 Xencor Company Information
6.20.2 Xencor Description and Business Overview
6.20.3 Xencor Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Xencor Bispecific Antibody Medicine Product Portfolio
6.20.5 Xencor Recent Developments/Updates
6.21 Zymeworks
6.21.1 Zymeworks Company Information
6.21.2 Zymeworks Description and Business Overview
6.21.3 Zymeworks Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Zymeworks Bispecific Antibody Medicine Product Portfolio
6.21.5 Zymeworks Recent Developments/Updates
6.22 MacroGenics, Inc
6.22.1 MacroGenics, Inc Company Information
6.22.2 MacroGenics, Inc Description and Business Overview
6.22.3 MacroGenics, Inc Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.22.4 MacroGenics, Inc Bispecific Antibody Medicine Product Portfolio
6.22.5 MacroGenics, Inc Recent Developments/Updates
6.23 Genmab
6.23.1 Genmab Company Information
6.23.2 Genmab Description and Business Overview
6.23.3 Genmab Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Genmab Bispecific Antibody Medicine Product Portfolio
6.23.5 Genmab Recent Developments/Updates
6.24 Immunocore Limited
6.24.1 Immunocore Limited Company Information
6.24.2 Immunocore Limited Description and Business Overview
6.24.3 Immunocore Limited Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Immunocore Limited Bispecific Antibody Medicine Product Portfolio
6.24.5 Immunocore Limited Recent Developments/Updates
6.25 Affimed
6.25.1 Affimed Company Information
6.25.2 Affimed Description and Business Overview
6.25.3 Affimed Bispecific Antibody Medicine Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Affimed Bispecific Antibody Medicine Product Portfolio
6.25.5 Affimed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bispecific Antibody Medicine Industry Chain Analysis
7.2 Bispecific Antibody Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bispecific Antibody Medicine Production Mode & Process Analysis
7.4 Bispecific Antibody Medicine Sales and Marketing
7.4.1 Bispecific Antibody Medicine Sales Channels
7.4.2 Bispecific Antibody Medicine Distributors
7.5 Bispecific Antibody Medicine Customer Analysis
8 Bispecific Antibody Medicine Market Dynamics
8.1 Bispecific Antibody Medicine Industry Trends
8.2 Bispecific Antibody Medicine Market Drivers
8.3 Bispecific Antibody Medicine Market Challenges
8.4 Bispecific Antibody Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Bispecific Antibody Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Bispecific Antibody Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Bispecific Antibody Medicine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Bispecific Antibody Medicine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Bispecific Antibody Medicine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Bispecific Antibody Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Bispecific Antibody Medicine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Bispecific Antibody Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Bispecific Antibody Medicine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bispecific Antibody Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bispecific Antibody Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Bispecific Antibody Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bispecific Antibody Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibody Medicine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bispecific Antibody Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Bispecific Antibody Medicine Sales by Region (2020-2025) & (K Units)
Table 18. Global Bispecific Antibody Medicine Sales Market Share by Region (2020-2025)
Table 19. Global Bispecific Antibody Medicine Sales by Region (2026-2031) & (K Units)
Table 20. Global Bispecific Antibody Medicine Sales Market Share by Region (2026-2031)
Table 21. Global Bispecific Antibody Medicine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Bispecific Antibody Medicine Revenue Market Share by Region (2020-2025)
Table 23. Global Bispecific Antibody Medicine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Bispecific Antibody Medicine Revenue Market Share by Region (2026-2031)
Table 25. North America Bispecific Antibody Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Bispecific Antibody Medicine Sales by Country (2020-2025) & (K Units)
Table 27. North America Bispecific Antibody Medicine Sales by Country (2026-2031) & (K Units)
Table 28. North America Bispecific Antibody Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Bispecific Antibody Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Bispecific Antibody Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Bispecific Antibody Medicine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Bispecific Antibody Medicine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Bispecific Antibody Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Bispecific Antibody Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Bispecific Antibody Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Bispecific Antibody Medicine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Bispecific Antibody Medicine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Bispecific Antibody Medicine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Bispecific Antibody Medicine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Bispecific Antibody Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Bispecific Antibody Medicine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Bispecific Antibody Medicine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Bispecific Antibody Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Bispecific Antibody Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Bispecific Antibody Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Bispecific Antibody Medicine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Bispecific Antibody Medicine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Bispecific Antibody Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Bispecific Antibody Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Bispecific Antibody Medicine Sales (K Units) by Type (2020-2025)
Table 51. Global Bispecific Antibody Medicine Sales (K Units) by Type (2026-2031)
Table 52. Global Bispecific Antibody Medicine Sales Market Share by Type (2020-2025)
Table 53. Global Bispecific Antibody Medicine Sales Market Share by Type (2026-2031)
Table 54. Global Bispecific Antibody Medicine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Bispecific Antibody Medicine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Bispecific Antibody Medicine Revenue Market Share by Type (2020-2025)
Table 57. Global Bispecific Antibody Medicine Revenue Market Share by Type (2026-2031)
Table 58. Global Bispecific Antibody Medicine Price (US$/Unit) by Type (2020-2025)
Table 59. Global Bispecific Antibody Medicine Price (US$/Unit) by Type (2026-2031)
Table 60. Global Bispecific Antibody Medicine Sales (K Units) by Application (2020-2025)
Table 61. Global Bispecific Antibody Medicine Sales (K Units) by Application (2026-2031)
Table 62. Global Bispecific Antibody Medicine Sales Market Share by Application (2020-2025)
Table 63. Global Bispecific Antibody Medicine Sales Market Share by Application (2026-2031)
Table 64. Global Bispecific Antibody Medicine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Bispecific Antibody Medicine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Bispecific Antibody Medicine Revenue Market Share by Application (2020-2025)
Table 67. Global Bispecific Antibody Medicine Revenue Market Share by Application (2026-2031)
Table 68. Global Bispecific Antibody Medicine Price (US$/Unit) by Application (2020-2025)
Table 69. Global Bispecific Antibody Medicine Price (US$/Unit) by Application (2026-2031)
Table 70. Roche (Genentech) Company Information
Table 71. Roche (Genentech) Description and Business Overview
Table 72. Roche (Genentech) Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche (Genentech) Bispecific Antibody Medicine Product
Table 74. Roche (Genentech) Recent Developments/Updates
Table 75. Amgen Company Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Amgen Bispecific Antibody Medicine Product
Table 79. Amgen Recent Developments/Updates
Table 80. Regeneron Pharmaceuticals Company Information
Table 81. Regeneron Pharmaceuticals Description and Business Overview
Table 82. Regeneron Pharmaceuticals Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Regeneron Pharmaceuticals Bispecific Antibody Medicine Product
Table 84. Regeneron Pharmaceuticals Recent Developments/Updates
Table 85. AstraZeneca Company Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca Bispecific Antibody Medicine Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Novartis Company Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Novartis Bispecific Antibody Medicine Product
Table 94. Novartis Recent Developments/Updates
Table 95. Merck & Co. Company Information
Table 96. Merck & Co. Description and Business Overview
Table 97. Merck & Co. Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Merck & Co. Bispecific Antibody Medicine Product
Table 99. Merck & Co. Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Pfizer Bispecific Antibody Medicine Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Eli Lilly and Company Company Information
Table 106. Eli Lilly and Company Description and Business Overview
Table 107. Eli Lilly and Company Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Eli Lilly and Company Bispecific Antibody Medicine Product
Table 109. Eli Lilly and Company Recent Developments/Updates
Table 110. Johnson & Johnson Company Information
Table 111. Johnson & Johnson Description and Business Overview
Table 112. Johnson & Johnson Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Johnson & Johnson Bispecific Antibody Medicine Product
Table 114. Johnson & Johnson Recent Developments/Updates
Table 115. AbbVie Company Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. AbbVie Bispecific Antibody Medicine Product
Table 119. AbbVie Recent Developments/Updates
Table 120. Sanofi Company Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Sanofi Bispecific Antibody Medicine Product
Table 124. Sanofi Recent Developments/Updates
Table 125. Takeda Company Information
Table 126. Takeda Description and Business Overview
Table 127. Takeda Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Takeda Bispecific Antibody Medicine Product
Table 129. Takeda Recent Developments/Updates
Table 130. Lindis Biotech Company Information
Table 131. Lindis Biotech Description and Business Overview
Table 132. Lindis Biotech Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Lindis Biotech Bispecific Antibody Medicine Product
Table 134. Lindis Biotech Recent Developments/Updates
Table 135. Bristol Myers Squibb Company Information
Table 136. Bristol Myers Squibb Description and Business Overview
Table 137. Bristol Myers Squibb Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Bristol Myers Squibb Bispecific Antibody Medicine Product
Table 139. Bristol Myers Squibb Recent Developments/Updates
Table 140. Akeso Biopharma Company Information
Table 141. Akeso Biopharma Description and Business Overview
Table 142. Akeso Biopharma Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Akeso Biopharma Bispecific Antibody Medicine Product
Table 144. Akeso Biopharma Recent Developments/Updates
Table 145. Alphamab Oncology Company Information
Table 146. Alphamab Oncology Description and Business Overview
Table 147. Alphamab Oncology Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Alphamab Oncology Bispecific Antibody Medicine Product
Table 149. Alphamab Oncology Recent Developments/Updates
Table 150. Innovent Biologics Company Information
Table 151. Innovent Biologics Description and Business Overview
Table 152. Innovent Biologics Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Innovent Biologics Bispecific Antibody Medicine Product
Table 154. Innovent Biologics Recent Developments/Updates
Table 155. Wuhan YZY Biopharma Co., Ltd. Company Information
Table 156. Wuhan YZY Biopharma Co., Ltd. Description and Business Overview
Table 157. Wuhan YZY Biopharma Co., Ltd. Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Wuhan YZY Biopharma Co., Ltd. Bispecific Antibody Medicine Product
Table 159. Wuhan YZY Biopharma Co., Ltd. Recent Developments/Updates
Table 160. BeiGene Company Information
Table 161. BeiGene Description and Business Overview
Table 162. BeiGene Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. BeiGene Bispecific Antibody Medicine Product
Table 164. BeiGene Recent Developments/Updates
Table 165. Xencor Company Information
Table 166. Xencor Description and Business Overview
Table 167. Xencor Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Xencor Bispecific Antibody Medicine Product
Table 169. Xencor Recent Developments/Updates
Table 170. Zymeworks Company Information
Table 171. Zymeworks Description and Business Overview
Table 172. Zymeworks Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Zymeworks Bispecific Antibody Medicine Product
Table 174. Zymeworks Recent Developments/Updates
Table 175. MacroGenics, Inc Company Information
Table 176. MacroGenics, Inc Description and Business Overview
Table 177. MacroGenics, Inc Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. MacroGenics, Inc Bispecific Antibody Medicine Product
Table 179. MacroGenics, Inc Recent Developments/Updates
Table 180. Genmab Company Information
Table 181. Genmab Description and Business Overview
Table 182. Genmab Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Genmab Bispecific Antibody Medicine Product
Table 184. Genmab Recent Developments/Updates
Table 185. Immunocore Limited Company Information
Table 186. Immunocore Limited Description and Business Overview
Table 187. Immunocore Limited Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Immunocore Limited Bispecific Antibody Medicine Product
Table 189. Immunocore Limited Recent Developments/Updates
Table 190. Affimed Company Information
Table 191. Affimed Description and Business Overview
Table 192. Affimed Bispecific Antibody Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. Affimed Bispecific Antibody Medicine Product
Table 194. Affimed Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Bispecific Antibody Medicine Distributors List
Table 198. Bispecific Antibody Medicine Customers List
Table 199. Bispecific Antibody Medicine Market Trends
Table 200. Bispecific Antibody Medicine Market Drivers
Table 201. Bispecific Antibody Medicine Market Challenges
Table 202. Bispecific Antibody Medicine Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bispecific Antibody Medicine
Figure 2. Global Bispecific Antibody Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Bispecific Antibody Medicine Market Share by Type: 2024 & 2031
Figure 4. T Cell Redirection Type Product Picture
Figure 5. Immune Modulation Type Product Picture
Figure 6. Dual Pathway Blockade Type Product Picture
Figure 7. Global Bispecific Antibody Medicine Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Bispecific Antibody Medicine Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Bispecific Antibody Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Bispecific Antibody Medicine Market Size (2020-2031) & (US$ Million)
Figure 14. Global Bispecific Antibody Medicine Sales (2020-2031) & (K Units)
Figure 15. Global Bispecific Antibody Medicine Average Price (US$/Unit) & (2020-2031)
Figure 16. Bispecific Antibody Medicine Report Years Considered
Figure 17. Bispecific Antibody Medicine Sales Share by Manufacturers in 2024
Figure 18. Global Bispecific Antibody Medicine Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Bispecific Antibody Medicine Players: Market Share by Revenue in Bispecific Antibody Medicine in 2024
Figure 20. Bispecific Antibody Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Bispecific Antibody Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Bispecific Antibody Medicine Sales Market Share by Country (2020-2031)
Figure 23. North America Bispecific Antibody Medicine Revenue Market Share by Country (2020-2031)
Figure 24. United States Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Bispecific Antibody Medicine Sales Market Share by Country (2020-2031)
Figure 27. Europe Bispecific Antibody Medicine Revenue Market Share by Country (2020-2031)
Figure 28. Germany Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Bispecific Antibody Medicine Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Bispecific Antibody Medicine Revenue Market Share by Region (2020-2031)
Figure 35. China Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Bispecific Antibody Medicine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Bispecific Antibody Medicine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Bispecific Antibody Medicine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Bispecific Antibody Medicine Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Bispecific Antibody Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Bispecific Antibody Medicine by Type (2020-2031)
Figure 54. Global Revenue Market Share of Bispecific Antibody Medicine by Type (2020-2031)
Figure 55. Global Bispecific Antibody Medicine Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Bispecific Antibody Medicine by Application (2020-2031)
Figure 57. Global Revenue Market Share of Bispecific Antibody Medicine by Application (2020-2031)
Figure 58. Global Bispecific Antibody Medicine Price (US$/Unit) by Application (2020-2031)
Figure 59. Bispecific Antibody Medicine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
